Patent ID: 7419987
Filing Date: 2008-09-02
Classification: A61P,C07D

Abstract:
1. A method comprising administering a therapeutically effective amount of a 7-azaindole of the formula 1 or a physiologically tolerated salt thereof wherein n is 2; R with at least one of —OH, —SH, —NH with mono-, bi— or tri-cyclic, saturated or monounsaturated or multiunsaturated carboxylic groups with 3 to 14 ring elements; with mono-, bi— or tri-cyclic saturated or monounsaturated or multiunsaturated heterocyclic groups with 5 to 15 ring elements and 1 to 6 heteroatoms selected from the group consisting of N, O and S; or R with mono-, bi- or tri-cyclic, saturated or monounsaturated or multiunsaturated carbocyclic group with 3 to 14 ring elements, with mono-, bi- or tri-cyclic saturated or monounsaturated or multiunsaturated heterocylic groups with 5 to 15 ring elements and 1 to 6 heteroatoms selected from N, O and S; wherein said C R or -phenyl unsubstituted or monosubstituted or multi-substituted with —OH, —SH, NH or pyridyl, unsubstituted or monosubstituted or multisubstituted with NO wherein —NR R to a subject afflicted with at least one condition selected from the group consisting of dermatitis, atopic dermatitis, eczema, fascitis, eosinophilic fascitis, urticaria, uveitis, neurodermatitis, pyodermatitis, acne, rosacea-like dermatitis, lupus erythematosus, allergic skin disease, psoriasis and keratosis.